Clinical Trial Update: A Long Term, Safety Study of Apricitabine in HIV-infected Subjects [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 long-term safety study of apricitabine in HIV-infected subjects. It summarizes extended safety ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Apricitabine (Apricitabine)

Snippet

Sponsor: Avexa | Conditions: HIV Infection | Phase 2 | Status: COMPLETED